Abstract
Positron emission tomography (PET) allows quantitative measurements of regional physiological and biochemical processes to be made in vivo in humans. PET determines the three-dimensional distribution of activity in the organ being studied after the subject is administered a tracer labeled with a positron emitting radionuclide. Quantitation of the parameter under study is accomplished by the use of a mathematical model that describes the biochemical or physiological process being examined.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Morrish P.K., Sawle G.V., and Brooks D.J. 1995, Clinical and [18F]dopa PET findings in early Parkinson’s disease. J Neurol Neurosurg Psychiatry 59:597–600.
. Rakshi J.S., Uema T., Ito K., et al. 1996, Statistical parametric mapping of three dimensional 18F-dopa PET in early and advanced Parkinson’s disease [abstract]. Mov Disord 11:147.
Frost J.J., Rosier A.J., Reich S.G., et al. 1993, Positron emission tomographic imaging of dopamine transporter with “C-WIN 35,428 reveals marked declines in mild Parkinson’s disease. Ann Neurol 34:423431.
Joyce J.N. and Murray A. 1994, Distribution of DI- and D2-like dopamine receptors in human brain, in: Dopamine-receptors and transporters: pharmacology, structure, and function, H.B. Niznik, ed., Marcel Dekker, New York pp. 345–383.
Antonini A., Schwarz J., Oertel W.H., et al. 1994, “C-raclopride positron emission tomography in previous untreated patients with Parkinson’s disease: influence of L-dopa and lisuride therapy on striatal dopamine D2 receptors. Neurology 44:1325–1329.
Brooks D.J., Ibanez V., Sawle G.V., et al. 1990, Differing patterns of striatal 18F-dopa uptake in Parkinson’s disease, multiple system atrophy, and progressive supranuclear palsy. Ann Neurol 28:547–555.
Bum D.J., Sawle G.V., and Brooks D.J., 1994, Differential diagnosis of Parkinson’s disease, multiple system atrophy, and Steele-Richardson-Olszewski syndrome: discriminant analysis of striatal 18F-dopa PET data. J Neurol Neurosurg Psychiatry 57;278–284.
Antonini A., Leenders KL., Vontobel P., et al. 1997, Complementary PET studies of striatal neuronal function in the differential diagnosis between multiple system atrophy and Parkinson’s disease. Brain 120:2187–2195.
. Brooks D.J., Ibanez V., Sawle G.V., et al. 1992, Striatal D2 receptors in patients with Parkinson’s disease, Striatonigral degeneration, and progressive supranuclear palsy measured with “C-raclopride and positron emission tomography. Ann Neurol 31:184–192.
Gambhir S.S., Barrio J., Wu L., et al. 1998 Imaging of adenoviral directed herpes simplex virus type 1 thymidine kinase gene expression n mice with ganciclovir. J Nucl Med 39:2003–2011.
Gambhir S.S., Barrio J.R., Iyer M., et al. 1999, In vivo validation of PET reporter gene/reporter probe assay for herpes simplex virus type I thymidine kinase with 8-[F-18]-fluoropenciclovir [abstract]. J Nucl Med 40:25P–26P.
Hustinx R., Eck S.L., and Alavi A. 1999, Potential applications of PET imaging in developing novel cancer therapies. J Nucl Med 40:995–1002.
Hustinx R., Shiue C.,Y., Alavi A., et al. 2001, Imaging in vivo herpes simplex virus thymidine kinase gene transfer to tumour-bearing rodents using positron emission tomography and [18F]FHPG. Eur J Nucl Med 28:5–12.
MacLaren D.C., Gambhir S.S., Satyamurthy N., et al. 1999, Repetitive, non-invasive imaging of the dopamine D2receptor as a reporter gene in living animals. Gene Therapy 6:785–791.
MacLaren D.C., Toyokuni T., Cherry S.R., et al. 2000, PET imaging of transgene expression. Biol Psychiatry 48:337–348.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer Science+Business Media New York
About this chapter
Cite this chapter
Reivich, M. (2003). Molecular Imaging by PET. In: Wilson, D.F., Evans, S.M., Biaglow, J., Pastuszko, A. (eds) Oxygen Transport To Tissue XXIII. Advances in Experimental Medicine and Biology, vol 510. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-0205-0_39
Download citation
DOI: https://doi.org/10.1007/978-1-4615-0205-0_39
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-4964-8
Online ISBN: 978-1-4615-0205-0
eBook Packages: Springer Book Archive